Coulter; Thomas Stephen
Patent Applications and Registrations
Patent applications and USPTO patent grants for Coulter; Thomas Stephen.The latest application filed is for "spiroindolinepiperidine derivatives".
- Coulter; Thomas Stephen - Abington GB
- Coulter; Thomas Stephen - Wantage N/A GB
- Coulter; Thomas Stephen - Oxfordshire Wantage GB
- Coulter; Thomas Stephen - Oxfordshire GB
- Coulter; Thomas Stephen - Abingdon GB
- Coulter; Thomas Stephen - Milton Park GB
| Patent | Date |
|---|---|
| Spiroindolinepiperidine derivatives Grant 9,686,990 - Hughes , et al. June 27, 2 | 2017-06-27 |
| Spiroindolinepiperidine Derivatives App 20160007608 - Hughes; David John ; et al. | 2016-01-14 |
| Spiroindolinepiperidine derivatives Grant 9,174,987 - Hughes , et al. November 3, 2 | 2015-11-03 |
| Pyrrolopyrimidines for pharmaceutical compositions Grant 8,697,713 - Jakel , et al. April 15, 2 | 2014-04-15 |
| Thienopyrimidines having Mnk1/Mnk2 inhibiting activity for pharmaceutical compositions Grant 8,633,201 - Aicher , et al. January 21, 2 | 2014-01-21 |
| Spiroindolinepiperidine Derivatives App 20120010220 - Hughes; David John ; et al. | 2012-01-12 |
| Mnk1 or Mnk2 inhibitors Grant 8,071,607 - Coulter , et al. December 6, 2 | 2011-12-06 |
| Indole, azaindole and related heterocyclic N-substituted piperazine derivatives Grant 8,039,486 - Yeung , et al. October 18, 2 | 2011-10-18 |
| Piperazine Compounds For The Inhibition Of Haematopoietic Prostaglandin D Synthase App 20100234377 - Aicher; Babette ; et al. | 2010-09-16 |
| Thienopyrimidines For Pharmaceutical Compositions App 20100143341 - Taylor; Steven ; et al. | 2010-06-10 |
| Pyrrolopyrimidines For Pharmaceutical Compositions App 20100105708 - Jakel; Stefan ; et al. | 2010-04-29 |
| Thienopyrimidines Having Mnk1/mnk2 Inhibiting Activity For Pharmaceutical Compositions App 20100056548 - Aicher; Babette ; et al. | 2010-03-04 |
| Alpha-substituted Arylmethyl Piperazine Pyrazolo [1,5-alpha]Pyrimidine Amide Derivatives App 20090215778 - Nitz; Theodore J. ; et al. | 2009-08-27 |
| MNK1 or MNK2 Inhibitors App 20090163520 - Coulter; Thomas Stephen ; et al. | 2009-06-25 |
| 11beta-hsdi inhibitors App 20090069323 - Coulter; Thomas Stephen ; et al. | 2009-03-12 |
| Indole, Azaindole And Related Heterocyclic N-substituted Piperazine Derivatives App 20080132516 - Yeung; Kap-Sun ; et al. | 2008-06-05 |
| Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer App 20070299102 - Felding; Jakob ; et al. | 2007-12-27 |
| Immunomodulatory compounds App 20060217411 - Matthews; Ian Richard ; et al. | 2006-09-28 |
| Novel betulin derivatives, preparation thereof and use thereof App 20060205697 - Robinson; Gary N. ; et al. | 2006-09-14 |
| Immunomodulatory compounds Grant 7,081,456 - Matthews , et al. July 25, 2 | 2006-07-25 |
| Spiroindolinepiperidine derivatives App 20060106045 - Hughes; David John ; et al. | 2006-05-18 |
| Indole, azaindole and related heterocyclic N-substituted piperazine derivatives App 20050261296 - Yeung, Kap-Sun ; et al. | 2005-11-24 |
| Immunomodulatory compounds App 20050203118 - Matthews, Ian Richard ; et al. | 2005-09-15 |
| Indole, azaindole and related heterocyclic N-substituted piperazine derivatives App 20050075364 - Yeung, Kap-Sun ; et al. | 2005-04-07 |
| Immunomodulatory compounds App 20040116461 - Matthews, Ian Richard ; et al. | 2004-06-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 